Novo Nordisk A S (NONOF) stock
NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$38.24−0.60 (-1.53%)
Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –
Novo Nordisk A S total assets
Total assets on the balance sheet at the end of each period.
Novo Nordisk A S's total assets was 542.90B DKK at Dec 31, 2025. For fiscal 2025 it was 542.90B DKK, up 16.6% from the year before. Over ten years it grew 19.5% a year on average. The highest annual figure on record is 542.90B DKK in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 542.90B DKK | +16.6% |
| FY2024 | Dec 31, 2024 | 465.63B DKK | +48.1% |
| FY2023 | Dec 31, 2023 | 314.49B DKK | +30.4% |
| FY2022 | Dec 31, 2022 | 241.26B DKK | +24.0% |
| FY2021 | Dec 31, 2021 | 194.51B DKK | +34.2% |
| FY2020 | Dec 31, 2020 | 144.92B DKK | +15.4% |
| FY2019 | Dec 31, 2019 | 125.61B DKK | +13.4% |
| FY2018 | Dec 31, 2018 | 110.77B DKK | +8.2% |
| FY2017 | Dec 31, 2017 | 102.36B DKK | +4.9% |
| FY2016 | Dec 31, 2016 | 97.54B DKK | +6.3% |
| FY2015 | Dec 31, 2015 | 91.80B DKK | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 542.90B DKK | +179.1% |
| Q4 FY2024 | Dec 31, 2024 | 465.63B DKK | +221.3% |
| Q4 FY2023 | Dec 31, 2023 | 314.49B DKK | +150.4% |
| Q4 FY2022 | Dec 31, 2022 | 241.26B DKK | +117.8% |
| Q4 FY2021 | Dec 31, 2021 | 194.51B DKK | +90.0% |
| Q4 FY2020 | Dec 31, 2020 | 144.92B DKK | +48.6% |
| Q4 FY2019 | Dec 31, 2019 | 125.61B DKK | +36.8% |
| Q4 FY2018 | Dec 31, 2018 | 110.77B DKK | – |
| Q4 FY2017 | Dec 31, 2017 | 102.36B DKK | – |
| Q4 FY2016 | Dec 31, 2016 | 97.54B DKK | – |
| Q4 FY2015 | Dec 31, 2015 | 91.80B DKK | – |
See a number that looks wrong?